“$39 billion market cap will require sales proje
Post# of 148293
(Total Views: 481)
Posted On: 04/05/2020 12:32:05 PM
Re: Rubraquercus #25542
“$39 billion market cap will require sales projections at least equal to or even in multiples of that annually.”
This is actually false. BP’s market caps are determined by a price/earnings ratio and that ratio is not 1, as you implied above (a $39 billion market cap would require $39 billion in sales).
Example: Johnson and Johnson has a current market cap of $353.73 billion. Their sales for fiscal year 2019 totaled $80+ billion. Their P/E ratio, without getting into sales vs profit, etc., is 23.82.
So, CYDY would not need annual sales of $39 billion to have a $39 billion dollar market cap. I’d say sales of $10-15 billion per year could result in a $35 billion dollar market cap, but probably higher if leronlimab is being sold for HIV (pending approval), cancer (still in trials), and other indications.
This is actually false. BP’s market caps are determined by a price/earnings ratio and that ratio is not 1, as you implied above (a $39 billion market cap would require $39 billion in sales).
Example: Johnson and Johnson has a current market cap of $353.73 billion. Their sales for fiscal year 2019 totaled $80+ billion. Their P/E ratio, without getting into sales vs profit, etc., is 23.82.
So, CYDY would not need annual sales of $39 billion to have a $39 billion dollar market cap. I’d say sales of $10-15 billion per year could result in a $35 billion dollar market cap, but probably higher if leronlimab is being sold for HIV (pending approval), cancer (still in trials), and other indications.
(9)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼